Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adenosine and Verapamil for No‐reflow During Primary Percutaneous Coronary Intervention in People With Acute Myocardial Infarction." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436527/1/. Accessed 08 May 2024.
Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436527/1/. Accessed May 8, 2024.
Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436527/1/
Adenosine and Verapamil for No‐reflow During Primary Percutaneous Coronary Intervention in People With Acute Myocardial Infarction [Internet]. In: Cochrane Abstracts. [cited 2024 May 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436527/1/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction
ID - 436527
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436527/1/
DB - Evidence Central
DP - Unbound Medicine
ER -